1
Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
Condition(s):Essential Hypertension; Type 2 Diabetes MellitusLast Updated:March 1, 2019Completed
Azilsartan Medoxomil: 59 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Condition(s):HypertensionLast Updated:November 20, 2019Completed
3
Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.
Condition(s):Arterial Hypertension; Diabetes Mellitus; Stable Chronic AnginaLast Updated:August 3, 2020Recruiting
4
Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension
Condition(s):HypertensionLast Updated:December 19, 2016Completed
5
Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients
Condition(s):Hypertension; Obesity; Type 2 Diabetes MellitusLast Updated:March 30, 2015Unknown status
6
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
Condition(s):Essential HypertensionLast Updated:April 23, 2014Completed
7
A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Condition(s):Pediatric HypertensionLast Updated:April 7, 2016Completed
8
Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension
Condition(s):Essential HypertensionLast Updated:March 5, 2019Completed
9
A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants
Condition(s):Healthy VolunteerLast Updated:February 5, 2020Completed
10
A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation
Condition(s):Japanese Healthy Adult Male ParticipantsLast Updated:November 14, 2018Completed